enow.com Web Search

  1. Ads

    related to: breakthrough in schizophrenia treatment protocol

Search results

  1. Results from the WOW.Com Content Network
  2. MDMA-assisted psychotherapy - Wikipedia

    en.wikipedia.org/wiki/MDMA-assisted_psychotherapy

    A phase III study indicated that MDMA-assisted therapy represents a potential breakthrough treatment for severe PTSD that merits expedited clinical evaluation. [17] Based on this study, MDMA-assisted psychotherapy was granted breakthrough therapy designation by the FDA, a designation that indicates that there is preliminary evidence that an intervention might offer a substantial improvement ...

  3. Ulotaront - Wikipedia

    en.wikipedia.org/wiki/Ulotaront

    The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [16] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [17]

  4. Management of schizophrenia - Wikipedia

    en.wikipedia.org/wiki/Management_of_schizophrenia

    It is more effective where symptoms of catatonia are present, [170] and is recommended for use under NICE guidelines in the UK for catatonia if previously effective, though there is no recommendation for use for schizophrenia otherwise. [171] Psychosurgery has now become a rare procedure and is not a recommended treatment for schizophrenia. [172]

  5. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...

  6. FDA approves new type of schizophrenia drug - AOL

    www.aol.com/news/fda-approves-type-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...

  7. Ralmitaront - Wikipedia

    en.wikipedia.org/wiki/Ralmitaront

    Ralmitaront (INN Tooltip International Nonproprietary Name, USAN Tooltip United States Adopted Name; developmental code names RG-7906 and RO-6889450) is an investigational antipsychotic drug which is undergoing a clinical trial for the treatment of negative symptoms in schizophrenia and schizoaffective disorder.

  1. Ads

    related to: breakthrough in schizophrenia treatment protocol